Search for: "Courtenay Brinckerhoff" Results 61 - 79 of 79
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
9 May 2014, 5:30 pm by Colin O'Keefe
Q & A on pregnancy and lactation accommodation - Winston-Salem attorney Robin Shea of Constangy on the firm’s blog, Employment & Labor Insider Baaaaad News For Patenting Cloned Sheep – Washington, DC lawyer Courtenay Brinckerhoff of Foley & Lardner on the firm’s blog, PharmaPatents Doctors Checking Prescriptions Decreases Drug Overdoses – Dallas attorney Kay Van Wey on her blog, AdvoKayte 10 Rules of Startup… [read post]
22 Dec 2015, 6:31 pm by Colin O'Keefe
– Philadelphia lawyer Wally Zimolong on his blog, Supplemental Conditions In Search of Leadership With An Authentic Voice – Chief Marketing Officer Eric Fletcher on his blog, Marketing Brain Fodder A Delicious Look At A Cookie Press Patent – Washington, DC lawyer Courtenay Brinckerhoff of Foley & Lardner on the firm’s blog, PharmaPatents For more of the best, check out LXBN, a complete review of the top insight and… [read post]
31 May 2012, 10:00 pm by Stephanie Figueroa
This article considers what technology companies are fighting over, their reasons for fighting, the impact on consumers, and the bottom line of the patent wars. 5) PharmaPatents: Patent Reform Q & A – Courtenay Brinckerhoff, Foley & Lardner Partner and Practice Center contributor, posted on her blog the questions she received as a panelist at the AIPLA webinar, “Patent Prosecution Under The AIA.” [read post]
31 Aug 2012, 5:30 pm by Colin O'Keefe
– Washington, DC lawyer Courtenay Brinckerhoff of Foley & Lardner on the firm’s blog, PharmaPatents For more of the best, check out LXBN, a complete review of the top insight and commentary across the LexBlog Network.   [read post]
21 Jan 2015, 5:37 pm by Colin O'Keefe
– Washington, DC lawyer Courtenay Brinckerhoff of Foley & Lardner on the firm’s blog, PharmaPatents For more of the best, check out LXBN, a complete review of the top insight and commentary across the LexBlog Network. [read post]
15 Jan 2014, 5:30 pm by Colin O'Keefe
Supreme Court – Vancouver, WA attorney Terry Briscoe of Stoel Rives on the Stoel Rives World of Employment Federal Circuit Splits The Baby In Patent Term Adjustment Decision – Washington, DC lawyer Courtenay Brinckerhoff of Foley & Lardner on the firm’s blog, PharmaPatents Court Strikes Net Neutrality Rules, Leaves Path for Other Broadband Regulations – Washington, DC lawyer Michael Beder of Covington & Burling on the… [read post]
9 May 2014, 9:44 am by Justin E. Gray
  Courtenay Brinckerhoff explains that "the Federal Circuit decision here does not appear to break much new ground, because the burden-shifting framework it supports is common to every issue that examiners raise. [read post]
8 Jul 2010, 5:00 am by Dennis Crouch
Kappos: Effects on Biotechnology Patents Some New IP Blogs: PharmaPatentsBlog by Courtenay Brinckerhoff and her folks at the Foley law firm. [read post]
25 Mar 2012, 1:05 pm by Antoinette Konski
For additional analysis on Prometheus and its possible impact, see my colleague Courtenay Brinckerhoff’s March 22nd post. [read post]
21 Mar 2012, 8:25 am by Stephanie Figueroa
Check out these fantastic case summaries and opinion pieces: PharmaPatents: Justice Breyer Gets The Last Word And Invalidates Prometheus Personalized Medicine Claims - Courtenay Brinckerhoff provides a thorough summary of the decision in this article. [read post]
22 Aug 2007, 10:17 am
I spoke with Courtenay Brinckerhoff at Foley & Lardner briefly about the new rules and she expressed the concern that the rule changes may be especially problematic for the chemical, pharmaceutical and biotech arts. [read post]
20 Mar 2014, 6:14 am by Rob Robinson
 http://bit.ly/1eNHbZC (Ki Hwang, Geoff Wilcox)Actionable Intelligence for In-House CounselProviding in-house counsel with a weekly overview of significant legal and technology-related stories centered around the corporate risk topics of compliance, information governance, privacy and security.4 Accused in Law Firm Fraud Ignored a Maxim: Don’t Email – http://nyti.ms/1gXOWtL (Matthew Goldstein)5 Key Points About Patent Subject Matter Eligibility… [read post]